Sun Pharmaceutical Industries Limited — Important, 13-12-2024: General Updates

The Company has received a regulatory order from the Commissioner of Customs (Appeal), Mumbai-III, imposing a redemption fine of ₹40 crore in lieu of confiscation of imported goods, along with a penalty of ₹25.2 crore for short payment of customs duty. The order reflects a violation of customs regulations but the Company affirms that there will be no material impact on its financial or operational activities. The situation warrants cautious monitoring but does not appear to pose significant risks to the Company's outlook.